Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:257-265
Published online before print June 22, 2006, doi: 10.1161/01.RES.0000233316.17882.33
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/3/257    most recent
01.RES.0000233316.17882.33v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, S.
Right arrow Articles by Karsan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, S.
Right arrow Articles by Karsan, A.
Related Collections
Right arrow Angiogenesis
Right arrow Other Treatment
Right arrowRelated Article
(Circulation Research. 2006;99:257.)
© 2006 American Heart Association, Inc.


Molecular Medicine

Identification of Sokotrasterol Sulfate As a Novel Proangiogenic Steroid

Siun Murphy*, Bruno Larrivée*, Ingrid Pollet, Kyle S. Craig, David E. Williams, Xin-Hui Huang, Megan Abbott, Fred Wong, Cameron Curtis, Thomas P. Conrads, Timothy Veenstra, Mira Puri, York Hsiang, Michel Roberge, Raymond J. Andersen, Aly Karsan

From the Departments of Medical Biophysics (S.M., B.L., I.P., M.A., F.W., C.C., A.K.) and Pathology & Laboratory Medicine (A.K.), British Columbia Cancer Agency, Vancouver, Canada; Departments of Chemistry (K.S.C., D.E.W., X.-H.H., R.J.A.), Surgery (Y.H.), Biochemistry and Molecular Biology (M.R.), and Pathology & Laboratory Medicine (A.K.), University of British Columbia, Vancouver, Canada; Laboratory of Proteomics and Analytical Technologies (T.P.C., T.V.), SAIC-Frederick Inc, National Cancer Institute at Frederick, Md; and Department of Medical Biophysics (M.P.), Sunnybrook & Women’s College Health Sciences Centre, Toronto, Ontario, Canada.

Correspondence to Aly Karsan, Department of Medical Biophysics, British Columbia Cancer Agency, 675 West 10th Ave, Vancouver, British Columbia V5Z 1L3, Canada. E-mail akarsan{at}bccrc.ca

The potential to promote neovascularization in ischemic tissues using exogenous agents has become an exciting area of therapeutics. In an attempt to identify novel small molecules with angiogenesis promoting activity, we screened a library of natural products and identified a sulfated steroid, sokotrasterol sulfate, that induces angiogenesis in vitro and in vivo. We show that sokotrasterol sulfate promotes endothelial sprouting in vitro, new blood vessel formation on the chick chorioallantoic membrane, and accelerates angiogenesis and reperfusion in a mouse hindlimb ischemia model. We demonstrate that sulfation of the steroid is critical for promoting angiogenesis, as the desulfated steroid exhibited no endothelial sprouting activity. We thus developed a chemically synthesized sokotrasterol sulfate analog, 2ß,3{alpha},6{alpha}-cholestanetrisulfate, that demonstrated equivalent activity in the hindlimb ischemia model and resulted in the generation of stable vessels that persisted following cessation of therapy. The function of sokotrasterol sulfate was dependent on cyclooxygenase-2 activity and vascular endothelial growth factor induction, as inhibition of either cyclooxygenase-2 or vascular endothelial growth factor blocked angiogenesis. Surface expression of {alpha}vß3 integrin was also necessary for function, as neutralization of {alpha}vß3 integrin, but not ß1 integrin, binding abrogated endothelial sprouting and antiapoptotic activity in response to sokotrasterol sulfate. Our findings indicate that sokotrasterol sulfate and its analogs can promote angiogenesis in vitro and in vivo and could potentially be used for promoting neovascularization to relieve the sequelae of vasoocclusive diseases.


Key Words: angiogenesis • ischemia • endothelium


Related Article:

Small Molecule Approaches for Promoting Ischemic Tissue Vascularization
Federico Bussolino
Circ. Res. 2006 99: 231-233. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
F. Bussolino
Small Molecule Approaches for Promoting Ischemic Tissue Vascularization
Circ. Res., August 4, 2006; 99(3): 231 - 233.
[Full Text] [PDF]